We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

28 hedge funds and large institutions have $6.35M invested in ImmuCell in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more capital inflows, than outflows

Capital inflows: $933K | Capital outflows: $623K

27% more funds holding

Funds holding: 22 → 28 (+6)

0.91% less ownership

Funds ownership: 14.74% → 13.83% (-0.91%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
28
Holders Change
+6
Holders Change %
+27.27%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
7
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$116K
2
Northern Trust
Northern Trust
Illinois
+$59.7K
3
Mesirow Financial Investment Management
Mesirow Financial Investment Management
Illinois
+$48.5K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$46.2K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$31.4K

Top Sellers

Rank Fund Capital Flow
1
Cresset Asset Management
Cresset Asset Management
Illinois
-$526K
2
Renaissance Technologies
Renaissance Technologies
New York
-$49.8K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$25.4K
4
UBS Group
UBS Group
Switzerland
-$13.4K
5
Shufro Rose & Co
Shufro Rose & Co
New York
-$5.5K

ICCC Hedge Fund Activity: Q4 2024 in Review

28 of the 7,623 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2024, worth a combined $6.35M — up 49% from $4.27M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ICCC positions and 0 closed out — a net gain of 6 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $116K. The largest seller was Cresset Asset Management, cutting an estimated $526K.

  • 28 institutional investors held ImmuCell (ICCC) as of Q4 2024, up from 22 in Q3 2024.
  • Funds reported $6.35M of ImmuCell stock for Q4 2024, up 49% quarter-over-quarter.
  • 6 funds opened new ImmuCell positions in Q4 2024 and 0 closed out, a net change of +6 holders.
  • The largest ImmuCell buyer in Q4 2024 was Citadel Advisors, an estimated $116K added.
  • The largest ImmuCell seller in Q4 2024 was Cresset Asset Management, an estimated $526K sold.

Based on aggregated 13F filings for Q4 2024.